Every year, HMRC publishes figures that ought to embarrass the British business community: billions of pounds in research and development tax relief go unclaimed. Thousands of eligible companies — from software start-ups in Manchester to engineering firms in the Midlands — are filing their accounts, paying their corporation tax bills, and walking away without a penny of relief they were lawfully entitled to. The reason, almost invariably, is simply that they did not know the scheme existed, or did not believe their work qualified.
That is a costly assumption. For businesses prepared to look more closely, R&D tax credits represent one of the most generous incentives in the UK tax code — and one that can make a material difference to a company's cashflow and growth trajectory.
What R&D Tax Credits Actually Are
R&D tax credits are a government-backed incentive designed to encourage businesses to invest in innovation. Administered by HMRC, the scheme allows companies to reduce their corporation tax liability, or in some cases receive a direct cash payment, in proportion to the qualifying research and development expenditure they have incurred.
The scheme has two main tracks. Small and medium-sized enterprises — broadly, companies with fewer than 500 employees and either a turnover below €100 million or a balance sheet below €86 million — historically claimed under the SME R&D Relief scheme, which offered enhanced deductions of up to 130 per cent on qualifying costs. Following reforms that took effect in April 2024, the landscape has been consolidated somewhat, with most companies now operating under a merged scheme, though certain R&D-intensive SMEs retain access to additional relief through the Enhanced R&D Intensive Support (ERIS) programme.
Larger companies have long claimed under the Research and Development Expenditure Credit (RDEC), which operates as an above-the-line credit, providing greater visibility in financial accounts. Under the merged scheme that replaced the old dual structure, the RDEC rate has risen, broadening the benefit for many.
The Eligibility Gap: Why So Many Businesses Miss Out
The most persistent myth surrounding R&D tax credits is that they are for pharmaceutical giants or aerospace manufacturers — organisations with gleaming laboratories and scientists in white coats. In reality, HMRC's definition of qualifying R&D is considerably broader, and it is this misunderstanding that leaves so many claims unmade.
Under HMRC's guidelines, a project qualifies if it seeks to achieve an advance in overall knowledge or capability in a field of science or technology, and if it involves resolving scientific or technological uncertainties that are not readily deducible by a competent professional in the field. That definition encompasses a remarkable range of everyday business activity: a software company building a novel data processing architecture, a food manufacturer reformulating a product to extend shelf life, a logistics firm developing bespoke route-optimisation algorithms, or a construction business experimenting with new materials to meet evolving building regulations.
Staff costs are the most significant qualifying expenditure category — typically accounting for the majority of most claims — but the relief also extends to subcontractor costs, consumable materials used in R&D activity, software licences, and utilities directly attributable to R&D work.
The two-year look-back window compounds the opportunity. Companies can file retrospective claims for up to two completed accounting periods, meaning a business that has never made a claim could potentially recover a substantial sum from work already completed.
The Claims Process and Recent HMRC Scrutiny
Filing an R&D claim requires submitting an Additional Information Form to HMRC alongside the corporation tax return, providing a technical narrative that explains the nature of the advance being sought and the uncertainties overcome. Since HMRC tightened its compliance procedures in 2023, the quality of this documentation has become paramount.
HMRC has been candid about its concerns regarding the volume of fraudulent and erroneous claims that emerged during the post-pandemic period, and the agency significantly ramped up enquiry activity as a result. For legitimate claimants, this increased scrutiny underlines the importance of maintaining robust records throughout the R&D process — project logs, technical meeting notes, version histories, and testing records all provide evidential support should HMRC raise questions.
The practical implication for companies approaching a first claim is that specialist advice is almost always worthwhile. R&D tax credit advisers — and a growing number of chartered accountancy practices — can assess eligibility, assist in compiling the technical narrative, and help quantify qualifying expenditure in a way that stands up to review. Fees are typically charged on a contingency basis, aligning the adviser's incentive with the client's outcome.
Cashflow timing is also worth considering. Even with a valid claim submitted, the HMRC processing period means a company may wait several months before relief materialises. For businesses that need working capital in the interim — particularly loss-making start-ups anticipating a payable cash credit — short-term bridging finance can be a practical solution. Lenders such as Credicorp, which offers short-term business loans without requiring a personal guarantee, are among the options available to companies managing the gap between filing a claim and receiving funds.
Making the Most of the Scheme Going Forward
The reforms introduced in 2024 have brought a degree of simplification, but also some reduction in generosity for SMEs that do not meet the R&D-intensity threshold for ERIS support. Companies operating across both the old SME scheme and RDEC — known as "subsidised" claimants — should revisit their position under the merged scheme to ensure they are maximising their entitlement.
Looking ahead, the government has signalled a continued commitment to incentivising private sector R&D investment, underpinned by concerns about the UK's productivity gap relative to comparable economies. The combined value of R&D tax relief claimed across the UK economy runs into billions annually, yet the gap between eligible expenditure and claimed relief remains substantial.
The businesses best positioned to benefit are those that integrate R&D tracking into their normal project management and accounting processes from the outset, rather than retrospectively reconstructing activity at year-end. Keeping contemporaneous records, clearly identifying which projects involve genuine technological uncertainty, and separating qualifying staff time from routine operational work all make the claims process considerably more straightforward.
For directors and finance teams who have dismissed R&D tax credits as irrelevant to their business, the case for a second look is compelling. The scheme was designed precisely for companies taking commercial risks in pursuit of innovation — and on that measure, the eligible population is far larger than the figures actually claiming would suggest.